Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early-stage breast carcinoma.
about
Chemotherapy-related cognitive impairment in older patients with cancerChemobrain: a critical review and causal hypothesis of link between cytokines and epigenetic reprogramming associated with chemotherapyRenaming "chemobrain"Cognitive function in breast cancer survivors compared to healthy age- and education-matched women.Opening up the window into "chemobrain": a neuroimaging reviewMemory and cancer: a review of the literatureBrain structure and function differences in monozygotic twins: possible effects of breast cancer chemotherapyChemotherapy-induced cognitive impairment is associated with decreases in cell proliferation and histone modifications.Retracted: Involvement of insulin-like growth factor-1 in chemotherapy-related cognitive impairment.Meta-analysis of cognitive functioning in breast cancer survivors previously treated with standard-dose chemotherapy.Symptom management of affective and cognitive disturbance with a group of cancer survivorsA meta-analysis of cognitive impairment and decline associated with adjuvant chemotherapy in women with breast cancer.Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adultsCan physical activity help to maintain cognitive functioning and psychosocial well-being among breast cancer patients treated with chemotherapy? A randomised controlled trial: study protocol.Effects of repeated administration of chemotherapeutic agents tamoxifen, methotrexate, and 5-fluorouracil on the acquisition and retention of a learned response in miceEffects of chemotherapeutic agents 5-fluorouracil and methotrexate alone and combined in a mouse model of learning and memory.Cognitive functioning after cancer treatment: a 3-year longitudinal comparison of breast cancer survivors treated with chemotherapy or radiation and noncancer controls.Candidate mechanisms for chemotherapy-induced cognitive changes.Cancer-related fatigue in post-treatment cancer survivors: application of the common sense model of illness representationsChemotherapy was not associated with cognitive decline in older adults with breast and colorectal cancer: findings from a prospective cohort study.Measures of fibromyalgia: Fibromyalgia Impact Questionnaire (FIQ), Brief Pain Inventory (BPI), Multidimensional Fatigue Inventory (MFI-20), Medical Outcomes Study (MOS) Sleep Scale, and Multiple Ability Self-Report Questionnaire (MASQ).The use of Ginkgo biloba for the prevention of chemotherapy-related cognitive dysfunction in women receiving adjuvant treatment for breast cancer, N00C9Cognitive functioning in breast cancer survivors: a controlled comparison.Magnitude and correlates of response shift in fatigue ratings in women undergoing adjuvant therapy for breast cancer.The role of specific and core dysfunctional beliefs in breast cancer radiotherapy patients' fatigue.Confronting chemobrain: an in-depth look at survivors' reports of impact on work, social networks, and health care response.Breast cancer treatment and cognitive function: the current state of evidence, underlying mechanisms and potential treatments.Development of CBT for chemotherapy-related cognitive change: results of a waitlist control trial.Neurocognitive effects of chemotherapy and endocrine therapies in the treatment of breast cancer: recent perspectives.Chemotherapy-related cognitive dysfunction.An evaluation on the neuropsychological tests used in the assessment of postchemotherapy cognitive changes in breast cancer survivors.Potential Use of Nicotinic Receptor Agonists for the Treatment of Chemotherapy-Induced Cognitive Deficits.Executive functioning impairment in women treated with chemotherapy for breast cancer: a systematic review.Systemic therapies and cognitive impairment for breast cancer: an overview of the current literature.Intra-individual variability in women with breast cancer.Decline in Cognitive Function in Older Adults With Early-Stage Breast Cancer After Adjuvant Treatment.Electroencephalogram power changes as a correlate of chemotherapy-associated fatigue and cognitive dysfunction.Study of the cognitive effects of chemotherapy: considerations in selection of a control group.Late effects of adjuvant chemotherapy for breast cancer on fine motor function.Quality of life more impaired in younger than in older diffuse large B cell lymphoma survivors compared to a normative population: a study from the population-based PROFILES registry.
P2860
Q26747612-608C78EB-EB77-415F-BE0E-90436FF2C62CQ27011451-E8BAC9F0-24A1-40FE-9653-0DBEFDE15E88Q28249848-6AB230E1-14D3-4F69-A574-0200CC644A42Q30458869-6ADF14B4-61C9-4B9D-A053-E203F7417E3DQ30596880-76D0759C-C0BF-453B-880E-93366103C703Q33663544-CF13C94F-27A5-4DC3-8041-DE8BF6FAD393Q34006211-ECDABC35-88D0-477F-BD45-09440F52C5E4Q34094748-1991B0DF-1FF5-433A-83A2-CA58AD43216AQ34173847-08AA8F5A-6565-4671-84E1-1F99324E2C5EQ34395112-7BA8B390-5535-447B-A0BE-1946F020B5E0Q34674401-3A2544EF-A718-4165-AF01-60BE96C55EF0Q35161191-C667C6B5-03E0-49AC-BEB4-0462CF8FDF84Q35164117-E912F06F-340F-46DC-A1FD-AA1016D3A938Q35611921-F0403E08-FC5B-4CD9-9E8B-AC4EDACC1198Q35644334-1C3399BB-1AD7-409C-AC22-53CAB38BD5AEQ35686715-72ADBE38-8660-4E64-BAF1-B049F5D89C2BQ35834672-215B5D97-6381-4056-82DE-8F995779A07BQ35898051-80A19A05-6370-4876-905E-BC410C1B7172Q36203521-8CE84ADA-AD27-4ECA-953D-AFB20DB364BEQ36240745-AC876857-620E-4222-AF63-80E981F72D7AQ36480034-28D442CB-F0D8-4591-A2DA-732082090BECQ36654247-1BF2EE08-99EE-4D37-B868-892A207D14B3Q37157773-DD4A3CA4-B14E-45DE-9658-DFB19C59C61FQ37192605-74E57966-C87B-413A-81D9-3AA72411ED64Q37330324-6D0E7DBB-53B3-40A9-ADB3-FE9BDA36916AQ37416152-07D8440E-3976-496B-94D5-F5D41285679DQ37585300-B41250A2-16AF-4B83-9DED-CC0CF253C719Q37639152-38A5B74D-73A7-41B8-9E34-1EDA2CB2CCB8Q37976412-DDE7F584-CB5A-48FF-BAFC-DA370C6579E5Q37997653-8A39343E-CFC6-4DF3-BDAC-D922C89151C4Q38000038-34E6FC94-07EF-4448-B0BA-5AF54EAF432AQ38344507-5FE8F647-164C-4ED7-BCA4-DAABC53D08A5Q38657842-986856BD-55E2-4BB5-B6AE-0F0BF33A11F6Q39212333-805B6651-2558-4158-9CF7-47F98515AADFQ39233062-3BACAC1F-D332-4133-A972-1512C4AFB7A5Q39544939-494E02D9-09AD-40FF-9487-4D4BE80228EBQ44585375-E2B23351-2647-4384-BB7E-A4DD027740A3Q45924447-6A4E1802-B219-4F33-8B11-F83621C66A1FQ48046482-D69584BA-5AAC-400D-8B86-022004FBA80DQ48120604-098643D2-E384-43D6-8230-286B47E014AF
P2860
Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early-stage breast carcinoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2005
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cognitive functioning after ad ...... early-stage breast carcinoma.
@en
Cognitive functioning after ad ...... early-stage breast carcinoma.
@nl
type
label
Cognitive functioning after ad ...... early-stage breast carcinoma.
@en
Cognitive functioning after ad ...... early-stage breast carcinoma.
@nl
prefLabel
Cognitive functioning after ad ...... early-stage breast carcinoma.
@en
Cognitive functioning after ad ...... early-stage breast carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
Cognitive functioning after ad ...... r early-stage breast carcinoma
@en
P2093
Frederick A Schmitt
Kristine A Donovan
Michael A Andrykowski
Pamela Munster
P2860
P304
P356
10.1002/CNCR.21482
P407
P577
2005-12-01T00:00:00Z